IGF Binding Protein-3 (IGFBP-3) is the most abundant carrier protein for insulin-like growth factors (IGF-1 and IGF-2) in the circulation, binding approximately 75-80% of all circulating IGFs in a ternary complex with an acid-labile subunit (ALS). It serves as both a transport protein that prolongs IGF half-life and a modulator of IGF bioavailability at the tissue level. IGFBP-3 is primarily synthesized in the liver under the regulation of growth hormone (GH) and has independent, IGF-independent biological activities including roles in apoptosis and cell proliferation. IGFBP-3 is regulated primarily by growth hormone through hepatic synthesis, and its circulating levels closely reflect GH secretory status, making it a useful surrogate marker of the GH/IGF axis. It forms a stable 150 kDa ternary complex with IGF-1 or IGF-2 and ALS, which restricts IGF passage across capillary endothelium and creates a circulating reservoir of IGFs. Proteolytic cleavage of IGFBP-3 by enzymes such as pregnancy-associated plasma protein-A (PAPP-A) releases free IGFs, allowing local tissue bioavailability to be regulated independently of circulating total IGF levels.
IGFBP-3 is a protein in your blood that carries and regulates the activity of growth factors, particularly IGF-1. It is closely linked to growth hormone and helps doctors assess whether your body is producing too much or too little growth hormone. High levels may suggest the body is making excess growth hormone, while low levels can indicate growth hormone deficiency, poor nutrition, or liver problems. Because levels change naturally with age and sex, your doctor will compare your result to ranges appropriate for your age and gender. This test is typically used alongside other tests to get a complete picture of your growth hormone system.
When elevated: Elevated IGFBP-3 levels may indicate growth hormone excess (acromegaly or gigantism), and in children may reflect accelerated growth or precocious puberty. High levels have also been associated with increased risk of certain hormone-sensitive cancers in epidemiological studies, though causality has not been established. Elevated IGFBP-3 in the context of normal or high IGF-1 supports evaluation for GH hypersecretion. When low: Low IGFBP-3 levels are associated with growth hormone deficiency, which may present as growth failure in children or metabolic abnormalities in adults. Reduced levels are also seen in states of protein malnutrition, hepatic insufficiency, and hypothyroidism, reflecting impaired hepatic synthetic capacity. Low IGFBP-3 in conjunction with low IGF-1 strengthens the clinical suspicion for GH deficiency or secondary causes of GH axis suppression.
IGFBP-3 reflects growth hormone status and IGF availability—both central to muscle protein synthesis, recovery, and adaptation to training. Athletes may find this useful as part of a broader GH/IGF axis assessment, particularly when investigating recovery quality, training tolerance, or age-related changes in anabolic capacity; however, it is a supporting marker rather than a primary performance indicator.
Fasting Required
No
Method
Immunochemiluminometric assay (ICMA)
Order online
Choose your lab and check out. We send your lab requisition automatically — no doctor visit needed.
Get your sample collected
Visit a lab service center near you for a quick blood draw (or book at-home phlebotomy where available).
See your results
Your results land in your Insider portal, ready to review and act on — that easy.
Your price
$54.90$140
2.6× less than retail
Versus the typical direct-to-consumer retail price for this test (illustrative — consumer prices vary by provider and region).
$54.90
$55.00
Peer-reviewed sources supporting the educational content on this page.